Your browser doesn't support javascript.
loading
A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of life.
van Andel, G; Fernandez de Moral, P; Caris, C T M; Carpentier, P; Wils, J; de Bruin, M J F M; Witjes, J A; Debruyne, F M J; Witjes, W P J.
Affiliation
  • van Andel G; Department of Urology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
World J Urol ; 21(3): 177-82, 2003 Aug.
Article in En | MEDLINE | ID: mdl-12819912
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Quality of Life / Epirubicin / Antibiotics, Antineoplastic Type of study: Clinical_trials / Observational_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: World J Urol Year: 2003 Document type: Article Affiliation country: Países Bajos Country of publication: Alemania
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Quality of Life / Epirubicin / Antibiotics, Antineoplastic Type of study: Clinical_trials / Observational_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: World J Urol Year: 2003 Document type: Article Affiliation country: Países Bajos Country of publication: Alemania